Pharmaceuticals

Qiming Venture Partners fosters life science, medical and healthcare talent development First healthcare catalyst program starts recruiting in Hong Kong universities

SHANGHAI and HONG KONG, June 15, 2023 /PRNewswire/ -- Qiming Venture Partners ("Qiming") today launched its first "Catalyst: Qiming Healthcare Summer Program 2023" for universities inHong Kong, fostering talent development and cross-border integration for the life science, medical and healthcare ...

2023-06-15 22:58 3038

Mabwell Announces the U.S. FDA approval of 9MW3811 for IND

SHANGHAI, June 15, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the entire value chain of the pharmaceutical industry, announced the clinical trial application of its self-developed 9MW3811 injection for idiopathic pulmonary fibrosis has been approved by ...

2023-06-15 21:00 1967

Mabwell Publishes the Preclinical Study Results on Its Nectin-4 Targeting ADC in A Well-known AACR Journal

SHANGHAI, June 15, 2023 /PRNewswire/ -- Recently, the preclinical study results of 9MW2821, the first domestically developed Nectin-4-targeting ADC by Mabwell, were published in the renowned journal "Molecular Cancer Therapeutics" under the American Association for Cancer Research (AACR). The pap...

2023-06-15 21:00 1972

China Jo-Jo Drugstores Reports Fiscal Year 2023 Financial Results

HANGZHOU, China, June 15, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced its finan...

2023-06-15 21:00 4435

Addentax Group Corp. in Advanced Talks to Acquire Partial Stake in RMB 6 Billion-Valued Recombinant Protein Drugs and Antibody Drugs Bio-pharmaceutical Company, Shanghai Bao Pharmaceutical Company Limited

SHENZHEN, China, June 15, 2023 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG), an integrated service provider focusing on garment manufacturing, logistics services, property management and subleasing, and epidemic prevention supplies, today announced that it is ...

2023-06-15 20:00 3867

FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer

SAN FRANCISCO, June 15, 2023 /PRNewswire/ -- Biostar Pharma, Inc. (hereinafter referred to as "Biostar"), the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative...

2023-06-15 19:31 1590

Springer Nature to Join Seegene's OneSystem™ Business as Strategic Partner

* Seegene announces strategic partnership with Springer Nature to expand OneSystem™ Business * Seegene and Springer Nature to jointly launch global assay development project * Springer Nature expresses active support for Seegene's vision to promote participation across global scientific com...

2023-06-15 19:00 1610

Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer

June 21, 2023, at The Yale Club, New York City  Featured speakers and Key Opinion Leaders include: Dr Christian Behrenbruch, DrColin Hayward, Kevin Richardson, Dr Brian Shuch and Dr Scott Tagawa Topics include Telix's urologic pipeline, development of novel therapeutics, imaging agents and techn...

2023-06-15 19:00 1628

111, Inc. Announces First Quarter 2023 Unaudited Financial Results

SHANGHAI, June 15, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the first quart...

2023-06-15 13:22 3303

Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen

TSURUOKA, Japan, June 15, 2023 /PRNewswire/ -- Metagen Therapeutics (President & CEO:Taku Nakahara), a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of1.7 b...

2023-06-15 13:00 2131

EW Group Signs with China's Largest Healthcare, Sinopharm

PETALING JAYA, Malaysia, June 15, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group), announced its partnership with HK VJM Ltd (representing Sinopharm Cloud Health Technology (Guandong) Co. and Sinopharm Traditional Chinese Medicine (Foshan) Co.) and NCL Solutions Sdn Bhd onApril...

2023-06-15 10:24 3182

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (...

2023-06-14 20:00 2498

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (...

2023-06-14 20:00 1901

Seegene and Werfen Partner to Collaborate on OneSystem™ Business to Develop Syndromic qPCR Assays

SEOUL, South Korea, June 14, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company which provides a total solution for PCR molecular diagnostics, announced an agreement with Werfen, a worldwide leader in Specialized Diagnostics, to advance discussions on the expansion of it...

2023-06-14 19:00 2004

Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test

SEOUL, South Korea, June 13, 2023 /PRNewswire/ -- Gencurix , a leading cancer molecular diagnostics company, has obtained approval from the Korean Ministry of Food and Drug Safety for its Droplex EGFR Mutation Test v2. This product is a companion diagnosti...

2023-06-14 09:00 1765

Sirnaomics to Present Latest Developments on GalAhead™ Therapeutic Platform at Upcoming Industry Conferences

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 14, 2023 /PRNewswire/ --  Sirnaomics Ltd.(the "Company"; stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that the...

2023-06-14 00:42 2399

Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drug

SAN FRANCISCO, June 12, 2023 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce...

2023-06-12 21:30 1920

Fresh2 Group Ltd. Regains Compliance with Nasdaq Listing Requirements

NEW YORK, June 12, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerc...

2023-06-12 21:00 3099

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson's Disease

* HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. * These mission-aligned companies are collaborating to develop small-molecule therapies for Parkinson's patients, benefiting from their combined expertise in clinical development and disease biology. * T...

2023-06-12 19:00 2358

The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang

NANCHANG, China, June 12, 2023 /PRNewswire/ -- From 28 to 30 May 2023, the 20th China Association of Clinical Laboratory Practice Expo (CACLP) and the 3rd China IVD Supply Chain Expo (CISCE), recognized as the world's leading in vitro diagnostics (IVD) exhibition, were successfully closed inNanch...

2023-06-12 18:45 2338
1 ... 56575859606162 ... 293